Skip to main content
. 2021 Jul 6;77(2):178–185. doi: 10.1136/thoraxjnl-2021-217205

Table 5.

Three-month outcomes by cluster

Event rate, n (%) Cluster 1
(n=79)
Cluster 2
(n=89)
Cluster 3
(n=67)
Cluster 4
(n=99)
Cluster 5
(n=119)
Cluster 6
(n=50)
P value*
All-cause death, life-saving CV intervention or hospitalisation for worsening HF 11 (13.9) 2 (2.2) 1 (1.5) 4 (4) 6 (5) 2 (4) <0.01
CV death or HF-related hospitalisation 8 (10.1) 2 (2.2) 1 (1.5) 3 (3) 5 (4.2) 1 (2) 0.07
All-cause death or all-cause hospitalisation 20 (25.3) 16 (18) 6 (9) 12 (12.1) 13 (10.9) 2 (4) <0.01
All-cause hospitalisation 16 (20.3) 16 (18) 6 (9) 11 (11.1) 13 (10.9) 1 (2) 0.02
HF-related hospitalisation 6 (7.6) 2 (2.2) 1 (1.5) 3 (3) 5 (4.2) 1 (2) 0.35
All-cause death 5 (6.3) 0 (0) 0 (0) 1 (1) 4 (3.4) 1 (2) 0.05
CV death 2 (2.5) 0 (0) 0 (0) 0 (0) 2 (1.7) 0 (0) 0.25

*Kruskal-Wallis test (quantitative variables) or χ2 test (qualitative variables).

CV, cardiovascular; HF, heart failure.